Hepatitis C antivirals' most common adverse effect is anemia

04/29/2013 | MedPage Today (free registration)

An analysis of data from more than 1,400 patients in the U.S. found that anemia is the most reported side effect of two direct-acting antiviral drugs used to treat patients with the hepatitis C virus. Researchers found that more than 50% of the patients who took boceprevir or telaprevir experienced anemia. The findings were presented at a liver disease research meeting in Europe.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA